Aytu Biopharma, Inc (AYTU) — DEF 14A Filings
All DEF 14A filings from Aytu Biopharma, Inc. Browse 3 Proxy Statement reports with AI-powered summaries and risk analysis.
DEF 14A Filings (3)
-
AYTU BioPharma Sets Dec. 10 Annual Meeting; Board Re-election, Auditor Ratification on Agenda
— Oct 24, 2025 Risk: low
Aytu BioPharma, Inc. (AYTU) is holding its Annual Meeting of Stockholders on December 10, 2025, at its Denver, Colorado office. Stockholders will vote on three -
Aytu BioPharma Files Definitive Proxy Statement
— Mar 28, 2025 Risk: low
AYTU BIOPHARMA, INC. filed its definitive proxy statement on March 28, 2025, for its annual meeting on May 21, 2025. The filing outlines the company's governanc -
Aytu BioPharma Announces 2024 Annual Meeting of Stockholders on June 26
— May 10, 2024 Risk: low
AYTU BIOPHARMA, INC (AYTU) filed a Proxy Statement (DEF 14A) with the SEC on May 10, 2024. Aytu BioPharma, Inc. will hold its 2024 annual meeting of stockholder
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX